New therapies on the horizon for hepatitis C: are we close?
- 28 February 2003
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 7 (1) , 211-242
- https://doi.org/10.1016/s1089-3261(02)00069-7
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Future therapy of hepatitis CHepatology, 2002
- Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid dropletsThe EMBO Journal, 2002
- RNA interferenceNature, 2002
- The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwindingThe EMBO Journal, 2002
- Domains I and II in the 5′ Nontranslated Region of the HCV Genome Are Required for RNA ReplicationBiochemical and Biophysical Research Communications, 2002
- Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA ReplicationJournal of Virology, 2001
- Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha InterferonAntimicrobial Agents and Chemotherapy, 2000
- Inhibition of Hepatitis C Virus Replication by Antisense Oligonucleotide in Culture CellsBiochemical and Biophysical Research Communications, 1995
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986